title: Hypersensitivity reactions to rituximab: 53 successful desensitizations in 7 patients with severe, near-fatal reactions.
authors.affiliation: Department of Hematology, Hadassah University Medical Center, Jerusalem, Israel.
authors.forename: Eyal
authors.initials: E
authors.lastname: Lebel
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center, Jerusalem, Israel.
authors.forename: Dina
authors.initials: D
authors.lastname: Ben-Yehuda
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center, Jerusalem, Israel.
authors.forename: Emilie
authors.initials: E
authors.lastname: Bohbot
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center, Jerusalem, Israel.
authors.forename: Zvi
authors.initials: Z
authors.lastname: Dranitzki
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center, Jerusalem, Israel.
authors.forename: Meir
authors.initials: M
authors.lastname: Shalit
authors.affiliation: Allergy and Clinical Immunology Unit, Department of Medicine, Hadassah University Medical Center, Jerusalem, Israel. Electronic address: yuvalt@hadassah.org.il.
authors.forename: Yuval
authors.initials: Y
authors.lastname: Tal
mesh_terms: D000328:Adult; D000368:Aged; D000074322:Antineoplastic Agents, Immunological / Q000009:adverse effects*; D003888:Desensitization, Immunologic / Q000706:statistics & numerical data*; D004342:Drug Hypersensitivity / Q000628:therapy*; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged; D012189:Retrospective Studies; D000069283:Rituximab / Q000009:adverse effects*
chemical_list: D000074322:Antineoplastic Agents, Immunological; D007155:Immunologic Factors; D000069283:Rituximab